Globenewswire

Search documents
Mortgage Rates Inch Up
Globenewswire· 2025-09-25 16:00
MCLEAN, Va., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.30%. “Following several weeks of decline, mortgage rates inched up this week,” said Sam Khater, Freddie Mac’s Chief Economist. “Housing market activity continues to hold up with purchase and refinance applications increasing by 18% and 42%, respectively, compared to the same time last year.” News Facts Th ...
Akropolis Group has closed the Galio Group acquisition transaction
Globenewswire· 2025-09-25 15:55
Akropolis Group, the leading Baltic shopping and entertainment centres development and management company, has today closed the Galio Group acquisition transaction and has become the sole owner of the shares of this company. “This is an important message for investors and business partners – this transaction ensures stable revenue growth and more development opportunities in the future. This acquisition of one of the leading real estate managers and developers in the country has enabled us to increase the ...
AbbVie's Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists
Globenewswire· 2025-09-25 15:53
EXTON, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Rheumatologists report high satisfaction with AbbVie’s Rinvoq (upadacitinib) following its recent approval in giant cell arteritis (GCA), with the majority citing anticipated efficacy, steroid-sparing benefits, and convenient oral administration as central drivers of adoption. Nearly all specialists are aware of the approval, and 40% have already prescribed Rinvoq for GCA patients, an early adoption curve that compares favorably with the brand’s prior launches i ...
Solvay integrates sustainability-linked features in all short-term liquidity reserves
Globenewswire· 2025-09-25 15:45
Press release Brussels, September 25, 2025 - 17h45 CEST Solvay has amended its €1.1 billion multilateral revolving credit facility and its €0.3 billion bilateral revolving credit facilities to incorporate sustainability-linked features, aligning with its For Generations roadmap and reinforcing its commitment to reducing greenhouse gas (GHG) emissions. These amendments directly link the company’s cost of borrowing to its climate ambitions, specifically the achievement of ambitious greenhouse gas (GHG) emiss ...
Eesti Energia has withdrawn its rating with S&P
Globenewswire· 2025-09-25 15:45
On 25 September 2025, Eesti Energia has withdrawn its long-term issuer credit rating with S&P Global Ratings. At the time of the withdrawal the rating stood at BB+ with a negative outlook. The withdrawal of the rating does not affect the Company’s financial position, ongoing operations, or obligations towards its investors and stakeholders. The Company remains committed to maintaining transparency and will continue to hold ratings from Moody’s and Fitch Danel FreibergHead of Treasury and Financial Risk Mana ...
Flow Traders 3Q 2025 Pre-Close Call
Globenewswire· 2025-09-25 15:45
Flow Traders 3Q 2025 Pre-Close Call Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) publishes the 3Q 2025 pre-close call script to be used with analysts post the market close on 25 September 2025. Welcome to the Flow Traders 3Q 2025 pre-close call, which is being conducted post the European market close on 25 September. During this call I will highlight relevant publicly available data and industry trends in our markets as well as previously published data by Flow Traders and relate these d ...
Cegedim’s profitability improving as expected in H1 2025
Globenewswire· 2025-09-25 15:45
Core Insights - Cegedim reported consolidated revenue of €322.5 million for H1 2025, reflecting a 1.1% increase year-on-year, with adjusted EBITDA rising to €61.2 million, a 17.2% increase [2][4][6] - The adjusted operating margin improved to 5.7% from 3.2% in 2024, indicating enhanced profitability across all divisions [2][4][9] Financial Performance - Revenue increased by €3.5 million, or 1.1%, from €319.0 million in H1 2024 to €322.5 million in H1 2025 [6] - Like-for-like revenue growth was reported at 2.8%, aligning with the Group's projections [6] - Adjusted EBITDA reached €61.2 million, representing 19.0% of revenue, up from 16.4% in the previous year [4][5] - Recurring operating income rose significantly by 63.2% to €16.9 million, compared to €10.3 million in H1 2024 [3][9] Cost Management - The increase in adjusted EBITDA was attributed to effective cost management, particularly in reducing external costs and optimizing workforce utilization [7] - Depreciation and amortization expenses increased slightly by €0.8 million, primarily due to higher R&D amortization [8] Division Performance - Revenue from the Software & Services division decreased by 5.1% to €144.4 million, while adjusted operating income improved to €1.9 million from a loss of €1.4 million [12][14] - The Flow division saw a revenue increase of 7.8%, driven by growth in digitalization services [16] - The Data & Marketing segment experienced robust growth, with revenue up 10.8% and adjusted operating income rising by 75.6% [22] Strategic Developments - Cegedim's decarbonization targets were validated by the Science Based Targets initiative (SBTi), reflecting the company's commitment to sustainability [18] - The Group transitioned its credit facility to a sustainability-linked loan, incorporating performance clauses related to ESG commitments [19] Future Outlook - The Group anticipates like-for-like revenue growth of 2-4% for 2025, with continued improvement in adjusted operating income expected [25]
Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
Globenewswire· 2025-09-25 15:35
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) - ...
Davis Commodities Studies Multi-Billion Cross-Border “Real Yield Token” Infrastructure to Power Next-Gen Health & Agri-Tech Markets
Globenewswire· 2025-09-25 15:25
Core Insights - Davis Commodities Limited is evaluating the expansion of its Real Yield Token (RYT) infrastructure into a multi-billion-dollar framework that connects sustainable agriculture with health innovation [1][2] - The company is exploring how RYT infrastructure could facilitate programmable, yield-backed financing for longevity and biotech sectors, leveraging over USD 12.5 billion committed by private capital [2][3] - The initiative is in an exploratory phase, with no commitment to token issuance or commercialization at this stage [3] Company Overview - Davis Commodities Limited is based in Singapore and specializes in trading agricultural commodities such as sugar, rice, and oil and fat products across various markets including Asia, Africa, and the Middle East [4] - The company operates under two main brands, Maxwill and Taffy, and provides complementary services like warehouse handling, storage, and logistics [4] - As of the fiscal year ended December 31, 2024, the company distributes its products to customers in over 20 countries [4] Financial and Operational Insights - The company has identified over USD 1 billion in tokenized issuance capacity for emerging-market agriculture and health-tech initiatives [8] - RYT-based liquidity pools are projected to achieve a settlement velocity that is over 20% faster than traditional trade finance mechanisms [8] - The company is focusing on ESG-oriented reserve structures that link food-chain asset performance with biotech innovation capital pools [8]
KBR SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against KBR, Inc. - KBR
Globenewswire· 2025-09-25 15:25
NEW ORLEANS, Sept. 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against KBR, Inc. (NYSE: KBR), if they purchased or otherwise acquired the Company’s securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Texas. Get Help KBR invest ...